TFM
HOWL icon

TFC Financial Management’s Werewolf Therapeutics HOWL Stock Holding History

TFC Financial Management’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.75K Hold
4,500
– – ﹤0.01% 485
2025
Q4 		$2.85K Buy
4,500
+2,000
+80% +$2.43K ﹤0.01% 497
2025
Q3 		$4.92K Hold
2,500
– – ﹤0.01% 461
2025
Q2 		$2.73K Hold
2,500
– – ﹤0.01% 476
2025
Q1 		$2.43K Hold
2,500
– – ﹤0.01% 473
2024
Q4 		$3.7K Buy
2,500
+1,000
+67% +$2.04K ﹤0.01% 445
2024
Q3 		$3.18K Hold
1,500
– – ﹤0.01% 458
2024
Q2 		$3.66K Buy
+1,500
New +$7.2K ﹤0.01% 420

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TFC Financial Management's HOWL Position: Q1 2026 in Review

TFC Financial Management held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 4,500 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

TFC Financial Management first reported a position in HOWL in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.92K in Q3 2025. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • TFC Financial Management held 4,500 shares of Werewolf Therapeutics worth $3.75K as of Q1 2026.
  • TFC Financial Management left its Werewolf Therapeutics share count unchanged in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q1 2026, its #485 holding.
  • TFC Financial Management first reported a position in Werewolf Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • TFC Financial Management's Werewolf Therapeutics position peaked at $4.92K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.